SNYNF:OTCMKTS
Sanofi SA
78,55 $
arrow_upward
+0,49%(+0,38) 1 p
15. okt, 16:00:00 GMT −4 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse SNYNF põhistatistika genereerimine…
Ava
78,55 $
Kõrge
78,55 $
Madal
78,55 $
Turu kapit.
98,14 mld
Keskm. maht
5,47 tuh
Maht
482,00
52 näd kõrgeim
106,34 $
52 näd madalaim
76,76 $
Beeta
0,32
Käibivad aktsiad
1,21 mld
Töötajate arv
75 tuh
Ava
78,55 $
Kõrge
78,55 $
Madal
78,55 $
Turu kapit.
98,14 mld
Keskm. maht
5,47 tuh
Maht
482,00
52 näd kõrgeim
106,34 $
52 näd madalaim
76,76 $
Beeta
0,32
Käibivad aktsiad
1,21 mld
Töötajate arv
75 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
ad-hoc-news.de
·
9 minuti eest
Sanofi stock pre-market at EUR 72.47 on October 16, 2026
Utah Business
·
7 tunni eest
Recursion prices $200M stock offering as Sanofi picks a partnered drug candidate
Yahoo Finance
·
10 tunni eest
Sanofi (ENXTPA:SAN) Stock Looks Reasonable After Its Antibody Deal
Quiver Quantitative
·
12 tunni eest
Recursion Pharmaceuticals Jumps After Sanofi Milestone, Clinical Updates, and $200 Million Financing
Profiil
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
Teave üksuse Sanofi SA kohta
TegevjuhtBelén Garijo | Paul Hudson
Töötajad74,8 tuh
Asutatud1973
PeakontoridPariis, Île-de-France, Prantsusmaa
Sektor-
Veebisaitsanofi.com